{"id":"W2619342418","doi":"10.1126/scitranslmed.aaf3962","title":"The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis","year":2017,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec","funders":"Daiichi Sankyo Europe; Medical Research Council; Daiichi Sankyo Foundation of Life Science; Japan Agency for Medical Research and Development; Parkinson's UK; Research Center Network for Realization of Regenerative Medicine; Japan Society for the Promotion of Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research","keywords":"Amyotrophic lateral sclerosis; Proto-oncogene tyrosine-protein kinase Src; ABL; Medicine; Neuroscience; Pharmacology; Cancer research; Biology; Receptor; Internal medicine; Tyrosine kinase; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003490361,0.0003108943,0.0004395217,0.0004325826,0.0003756591,0.0004226382,0.0002431927,0.0007016446,0.003720118],"category_scores_gemma":[0.0003160733,0.000105589,0.0002437596,0.0003599644,0.0005171837,0.0004296616,0.0002959224,0.0009221608,0.0007590992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004690125,"about_ca_system_score_gemma":0.0005381107,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007197713,"about_ca_topic_score_gemma":0.00137747,"domain_scores_codex":[0.9998931,0.0000218342,0.000008831731,0.00001533154,0.0000346758,0.00002629511],"domain_scores_gemma":[0.9999049,0.00002661772,0.00002106977,0.000007384188,0.00001598138,0.00002399361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001755245,0.0004723182,0.005553504,0.001047905,0.0001125281,0.003836942,0.0001242843,0.001606372,0.8121019,0.006188948,0.008279908,0.1589202],"study_design_scores_gemma":[0.001383991,0.005611849,0.07629655,0.0002799487,0.0005024115,0.03030601,0.0003876699,0.008994822,0.7336207,0.01229801,0.1302206,0.00009745362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8337511,0.1043779,0.00653632,0.009862809,0.0005873588,0.0001476518,0.0007003413,0.0005551821,0.04348143],"genre_scores_gemma":[0.9738184,0.01879092,0.001735703,0.0004626267,0.0001522084,0.00004590219,0.0003858491,0.00002224379,0.004586163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003720118,"threshold_uncertainty_score":0.01244497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06368197480743866,"score_gpt":0.3403339548035234,"score_spread":0.2766519799960848,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}